The National Agency for Food and Drug Administration and Control (NAFDAC) has dismissed claims circulating on social media that Camosunate, an antimalarial drug, has been banned in Nigeria.
The company disclosed this in a press launch dated November 21, 2026, signed by its Director-General, Professor Mojisola Adeyeye.
NAFDAC clarified that it has by no means banned Camosunate or medicines containing the artesunate-amodiaquine mixture, whereas acknowledging that some signs highlighted in the viral claims could also be related to recognized negative effects of the drug.
NAFDAC defined that Camosunate accommodates artesunate and amodiaquine, two energetic elements used in the remedy of malaria. It reiterated that there isn’t a ban on the drug or different medicines containing the identical mixture in Nigeria.
- “The National Agency for Food and Drug Administration and Control (NAFDAC) is refuting claims circulating on social media that Camosunate, an antimalarial medicine containing artesunate and amodiaquine, has been banned in Nigeria. The Agency clarifies that it has never banned Camosunate or medicines containing the artesunate-amodiaquine combination,” the assertion learn in half.
The company famous that some signs talked about in the circulating claims, together with nausea, vomiting, diarrhoea, stomach ache, headache, dizziness, drowsiness and lack of urge for food, are among the many recognized negative effects related to Camosunate.
However, NAFDAC burdened that suspected adversarial drug reactions ought to be reported for correct evaluation slightly than handled as affirmation that the drugs has been banned or is unsafe to be used.
The company inspired members of the general public and healthcare professionals to report suspected adversarial reactions by means of the NAFDAC Med Safety App, obtainable on Android and iOS units, or by visiting the closest NAFDAC workplace.
It additionally urged Nigerians to cease circulating the declare that Camosunate has been banned, describing the knowledge as false. Those who had already shared it had been inspired to flow into the company’s clarification by means of the identical channels to counter the misinformation.
Camosunate ban declare sparks Edo dispute
The controversy adopted a reported declaration by the Chairman of the Edo State Consumer Protection Committee, Osaro Iyamu, that Camosunate was a banned medicinal product in Nigeria.
The Association of Community Pharmacists of Nigeria (ACPN) subsequently gave Iyamu 24 hours to supply verifiable proof from NAFDAC supporting the declare or face attainable authorized motion.
- In an announcement, the affiliation’s National Chairman, Pharm. Ambrose Igwekamma Ezeh, mentioned its verification of NAFDAC’s Greenbook confirmed that Camosunate Children Powder, registration quantity 04-7908, manufactured by Front Pharmaceuticals PLC and marketed by Geneith Pharmaceuticals Limited, remained an energetic registered medication.
- ACPN mentioned the product was registered on November 26, 2025, with its registration legitimate till November 25, 2030.
- The affiliation demanded a public retraction and apology if Iyamu didn’t substantiate the alleged ban.
It additionally questioned a reported enforcement operation at ALSO CARE Pharmacy in Benin City, arguing that pharmaceutical inspections and enforcement ought to be carried out by legally authorised establishments, notably NAFDAC and the Pharmacy Council of Nigeria.
NAFDAC’s subsequent clarification that it had by no means banned Camosunate or medicines containing the artesunate-amodiaquine mixture addresses the drug’s regulatory standing. However, the company didn’t particularly reference the Edo committee’s declaration.
NAFDAC highlights medication verification measures
The clarification comes amid Nigeria’s continued wrestle with counterfeit, expired, unregistered and substandard medicines, with a number of enforcement operations highlighting the size of the issue.
On November 21, 2026, Nairametrics reported that NAFDAC destroyed fake, banned, expired, substandard and other violative products worth an estimated N100 billion at Ogwama Dumpsite, Ogere Remo, Ogun State.
The merchandise included banned and unregistered medicines, expired Codeine cough syrups, Analgin injections, counterfeit cosmetics and unwholesome meals merchandise.
During an interview on Channels Television’s Sunrise Daily, she mentioned the removing of duty for regulating patent medication sellers from the Pharmacy Council of Nigeria (PCN), and its eventual return, contributed to the emergence of open drug markets populated by individuals with out ample information of medicines.
Adeyeye acknowledged that addressing the issue would take time, noting that Nigeria had not constantly utilized worldwide requirements in drug registration in the previous. She mentioned NAFDAC now makes use of the Common Technical Document as a template for registering medicines.
Meanwhile, NAFDAC’s Greenbook, launched in December 2023, supplies a database by means of which shoppers and healthcare professionals can verify the registration standing of pharmaceutical merchandise.
